RSNA: Medrad highlights Certegra informatics platform
Medrad (Booth 4209) is highlighting its Certegra product platform, including Certegra P3T products and Certegra Connect.PACS, at the 2009 Radiological Society of North America (RSNA) in Chicago this month.
The Warrendale, Pa.-based company said its Certegra P3T products automate protocol personalization and improve contrast enhancement for CT angiography and abdominal studies. P3T Cardiac enhances CT angiography of cardiac structures, coronary arteries, chambers of the heart, thoracic aorta, abdominal aorta and pulmonary vasculature for pulmonary embolism studies.
Certegra’s Connect.PACS application makes available information to inform decision making, according to Medrad. The application integrates each patient’s CT contrast injection record with the associated clinical image sets stored in PACS. Connect.PACS automates recordkeeping, facilitates Joint Commission compliance and reduces manual records discrepancies. Administrators analyze standard or custom-designed key indicator reporting to gain insight for improving efficiency and productivity of radiology resources, the company said.
The Warrendale, Pa.-based company said its Certegra P3T products automate protocol personalization and improve contrast enhancement for CT angiography and abdominal studies. P3T Cardiac enhances CT angiography of cardiac structures, coronary arteries, chambers of the heart, thoracic aorta, abdominal aorta and pulmonary vasculature for pulmonary embolism studies.
Certegra’s Connect.PACS application makes available information to inform decision making, according to Medrad. The application integrates each patient’s CT contrast injection record with the associated clinical image sets stored in PACS. Connect.PACS automates recordkeeping, facilitates Joint Commission compliance and reduces manual records discrepancies. Administrators analyze standard or custom-designed key indicator reporting to gain insight for improving efficiency and productivity of radiology resources, the company said.